Candela‑Toha, A.M. (Ángel M.)

Filtering

20211

Settings

Author search.filters.isAuthorOfPublication.e6834c6e-109f-417e-b5de-abb952c33f88

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study
    (Springer Nature, 2021) Monedero, P. (Pablo); Gea, A. (Alfredo); Castro, P. (Pedro); Candela‑Toha, A.M. (Ángel M.); Hernández-Sanz, M.L. (María L.); Arruti, E. (Egoitz); Villar, J. (Jesús); Ferrando, C. (Carlos)
    Background: Critically ill patients with coronavirus disease 19 (COVID-19) have a high fatality rate likely due to a dysregulated immune response. Corticosteroids could attenuate this inappropriate response, although there are still some concerns regarding its use, timing, and dose. Methods: This is a nationwide, prospective, multicenter, observational, cohort study in critically ill adult patients with COVID-19 admitted into Intensive Care Units (ICU) in Spain from 12th March to 29th June 2020. Using a multivariable Cox model with inverse probability weighting, we compared relevant outcomes between patients treated with early corticosteroids (before or within the first 48 h of ICU admission) with those who did not receive early corticosteroids (delayed group) or any corticosteroids at all (never group). Primary endpoint was ICU mortality. Secondary endpoints included 7-day mortality, ventilator-free days, and complications. Results: A total of 691 patients out of 882 (78.3%) received corticosteroid during their hospital stay. Patients treated with early-corticosteroids (n = 485) had lower ICU mortality (30.3% vs. never 36.6% and delayed 44.2%) and lower 7-day mortality (7.2% vs. never 15.2%) compared to non-early treated patients. They also had higher number of ventilator-free days, less length of ICU stay, and less secondary infections than delayed treated patients. There were no differences in medical complications between groups. Of note, early use of moderate-to-high doses was associated with better outcomes than low dose regimens. Conclusion: Early use of corticosteroids in critically ill patients with COVID-19 is associated with lower mortality than no or delayed use, and fewer complications than delayed use.